This research demonstrates enhanced drug specificity and reduced toxicity in targeted therapeutics using peptide-drug conjugates, suggesting novel treatment pathways for complex diseases.
Peptide-drug conjugates (PDCs) represent an emerging class of targeted therapeutics engineered to enhance drug specificity and minimize systemic toxicity, showing significant promise for treating complex diseases. The peptide component is...
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: